京漢股份(000615.SZ):資管7號擬減持不超2%的股份
格隆匯3月23日丨京漢股份(000615.SZ)公佈,持有公司5%以上股份的股東證券行業支持民企發展系列之海通證券資管7號集合資產管理計劃(“資管7號”),計劃在自減持計劃預披露公告披露之日起15個交易日後的6個月內(即2020年4月15日至2020年10月15日),以集中競價方式減持公司股份不超過1564.6153萬股,佔公司總股本比例2%。
通過證券交易所集中競價交易方式進行減持的,任意連續90個自然日內減持總數不超過公司總股本的1%,減持價格根據市場價格確定。
根據相關協議,資管7號公告減持股份計劃,但長期看好公司經營發展前景,本公告只是根據合規性要求披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.